Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Abstract Background & Aims Oral antiviral therapy may reduce the disease progression of
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
Background In first-line treatment of Helicobacter pylori, we have previously shown that the
eradication frequency was 83· 7%(95% CI 80· 4–86· 6) for triple therapy for 14 days (T14; …
eradication frequency was 83· 7%(95% CI 80· 4–86· 6) for triple therapy for 14 days (T14; …
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
JM Liou, YJ Fang, CC Chen, MJ Bair, CY Chang… - The Lancet, 2016 - thelancet.com
Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-
day triple therapy for the first-line treatment of Helicobacter pylori infection remains poorly …
day triple therapy for the first-line treatment of Helicobacter pylori infection remains poorly …
[HTML][HTML] The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A …
JM Liou, CY Chang, MJ Chen, CC Chen, YJ Fang… - PLoS …, 2015 - journals.plos.org
Objective The Taiwan Government issued a policy to restrict antimicrobial usage since 2001.
We aimed to assess the changes in the antibiotic consumption and the primary resistance of …
We aimed to assess the changes in the antibiotic consumption and the primary resistance of …
[HTML][HTML] Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease
KC Hu, HY Wang, SC Liu, CC Liu… - World journal of …, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) refers to the accumulation of fat (mainly
triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general …
triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general …
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
JM Liou, CC Chen, CY Chang, MJ Chen, CC Chen… - Gut, 2016 - gut.bmj.com
Objective Significant heterogeneity was observed in previous trials that assessed the
efficacies of sequential therapy for 10 days (S10) versus triple therapy for 14 days (T14) in …
efficacies of sequential therapy for 10 days (S10) versus triple therapy for 14 days (T14) in …
Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection
Background & Aims We aimed to compare the efficacy of genotypic resistance–guided
therapy vs empirical therapy for eradication of refractory Helicobacter pylori infection in …
therapy vs empirical therapy for eradication of refractory Helicobacter pylori infection in …
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
PC Tsai, HT Kuo, CH Hung, KC Tseng, HC Lai… - Journal of …, 2023 - Elsevier
Background & Aims Diabetes mellitus (DM) is known to increase the risk of hepatocellular
carcinoma (HCC) among individuals with chronic hepatitis C (CHC). We aimed to evaluate …
carcinoma (HCC) among individuals with chronic hepatitis C (CHC). We aimed to evaluate …
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label …
MJ Chen, PY Chen, YJ Fang, MJ Bair… - The Lancet …, 2023 - thelancet.com
Background Helicobacter pylori infection is an important causal factor of gastric cancer and
peptic ulcer disease and is associated with immune thrombocytopenic purpura and …
peptic ulcer disease and is associated with immune thrombocytopenic purpura and …
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut …
Background Levofloxacin-based therapy or bismuth-based quadruple therapy are the
recommended second-line regimens for Helicobacter pylori eradication after failure of …
recommended second-line regimens for Helicobacter pylori eradication after failure of …